Insights

Reset

Featured

Insights

Private: ADVI Health Analysis Shows Slow Medicare Uptake of Humira Biosimilar

View Article

ADVI insights

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Perspectives: IRA Implementation and “Government Negotiation”
ADVI Instant

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: Draft Guidance for the “Medicare Rx Payment Plan” Program Release

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

IRA Update: ‘Bona Fide’ Marketing and the Latest on Government Negotiation
ADVI Aware

Insights,

| Christy Langston - Director

ADVI Aware: Key Health Policy Topics in July 2023
View All

Case Studies

Retrospective Study: SGLT-2 Inhibitors Rx Disparities and Affordability Among Medicare Patients with Diabetes

Assessing the Hypertension Market in Medicare and Medicaid Populations

Type 2 Diabetes Digital Therapeutics Reimbursement Strategy

Occupational Therapy, Valuation of New Assessment Codes
View All

Events

Events Join ADVI Expert Michael Beebe’s Healthcare Reimbursement Masterclass
Events ADVI’s Presenting at AMCP Nexus
Events Meet with ADVI Experts at Meeting on the Mesa
ADVI Health attends NextGen Summit Events ADVI Will Be Presenting at Upcoming 15th Annual Next Generation Dx Summit
Events ADVI Will Be Attending and Sponsoring Asembia’s AXS23 Summit
Events ADVI Presents at ISPOR
View All

News

In The News ADVI Teams Up with Mix Talent on Special Edition Cell and Gene Therapy Podcast
In The News Lindsay Bealor Greenleaf speaks with The Washington Times on Healthcare Costs and Premium Spikes
In The News ADVI Expert Discusses Medicare Drug Pricing Negotiation’s “Spillover Effect” With AIS Health
In The News ADVI Expert Discusses Inflation Reduction Act with Pink Sheet
In The News ADVI Launches ADVI Angle
In The News ADVI Welcomes New Vice President of Market Access
View All

Videos

Evolving Healthcare Landscape: Cell and Gene – Q2, 2023

Introduction to the Inflation Reduction Act
View All